Acar, C.; Yüksel, H.Ç.; Şahin, G.; Açar, F.P.; Karaca, B.
Exploring the Frequency and Risk Factors of Hyperprogressive Disease in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Curr. Oncol. 2024, 31, 6343-6355.
https://doi.org/10.3390/curroncol31100472
AMA Style
Acar C, Yüksel HÇ, Şahin G, Açar FP, Karaca B.
Exploring the Frequency and Risk Factors of Hyperprogressive Disease in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology. 2024; 31(10):6343-6355.
https://doi.org/10.3390/curroncol31100472
Chicago/Turabian Style
Acar, Caner, Haydar Çağatay Yüksel, Gökhan Şahin, Fatma Pinar Açar, and Burçak Karaca.
2024. "Exploring the Frequency and Risk Factors of Hyperprogressive Disease in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors" Current Oncology 31, no. 10: 6343-6355.
https://doi.org/10.3390/curroncol31100472
APA Style
Acar, C., Yüksel, H. Ç., Şahin, G., Açar, F. P., & Karaca, B.
(2024). Exploring the Frequency and Risk Factors of Hyperprogressive Disease in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology, 31(10), 6343-6355.
https://doi.org/10.3390/curroncol31100472